Automating ASCO Guidelines Prior Authorization Criteria with Klivira
Navigating the complexities of ASCO Guidelines prior authorization criteria for oncology treatments demands precision and efficiency. Klivira automates the validation and submission process, ensuring adherence to clinical standards and accelerating patient access to care.
Oncology practices face significant administrative burdens in securing prior authorizations, often complicated by the detailed, evolving nature of ASCO Guidelines. Manual review against these criteria introduces delays, increases denial rates, and diverts clinical staff from patient care. Klivira provides a structured solution to integrate these guidelines directly into your PA workflow.
The Challenge of ASCO Guidelines in Prior Authorization
The American Society of Clinical Oncology (ASCO) publishes evidence-based guidelines that are critical for quality cancer care and frequently referenced by payers for medical necessity determinations. Manually cross-referencing patient clinical data against these comprehensive and frequently updated guidelines for every prior authorization request is a time-intensive process, prone to human error, and a primary driver of administrative waste within revenue cycle operations.
How Klivira Automates ASCO Guideline Prior Authorization
- **Real-time Criteria Matching:** Klivira's platform ingests relevant ASCO Guidelines and payer-specific criteria, performing automated checks against patient data extracted from the EMR.
- **Data Aggregation and Pre-population:** Clinical documentation, lab results, and imaging reports are automatically gathered and structured to support medical necessity arguments aligned with ASCO criteria.
- **Smart Workflow Orchestration:** Requests are intelligently routed based on guideline adherence, flagging cases requiring physician review while accelerating straightforward approvals.
- **X12 278 and ePA Submission:** Facilitates electronic submission of prior authorization requests via industry-standard protocols, including X12 278 and ePA where applicable, streamlining communication with payers.
Seamless Integration with Oncology Workflows
Klivira integrates directly with leading EMR systems via SMART on FHIR and other secure APIs, embedding prior authorization automation within your existing clinical and administrative workflows. This ensures that ASCO guideline-based criteria checks occur early in the treatment planning process, minimizing downstream delays and reducing the administrative burden on oncology care teams. Data exchange is secure and compliant with HIPAA regulations, safeguarding PHI.
Driving Efficiency and Reducing Denial Rates
By automating the validation of ASCO Guidelines prior authorization criteria, Klivira significantly reduces the manual effort involved in PA submissions. This precision helps ensure that requests are submitted with complete and accurate clinical documentation, directly contributing to a reduction in initial denial rates and accelerating the time-to-treatment for oncology patients. The system provides clear audit trails for all decisions, supporting appeals processes.
Key Benefits for Oncology Practices and Health Systems
- Improve PA approval rates by ensuring guideline adherence.
- Reduce administrative overhead for prior authorization coordinators.
- Accelerate patient access to critical oncology treatments.
- Enhance data accuracy and consistency in PA submissions.
- Free up clinical staff to focus on patient care.
- Gain analytical insights into PA performance against ASCO criteria.
Frequently asked questions
How does Klivira access and interpret ASCO Guidelines for prior authorization?
Klivira integrates structured data from ASCO Guidelines and payer medical policies into its rules engine. Our platform then programmatically applies these criteria to patient clinical data extracted from your EMR, automating the assessment of medical necessity for specific oncology treatments.
Can Klivira integrate with my existing EMR system for oncology prior authorizations?
Yes, Klivira is designed for seamless integration with a wide range of EMRs, including Epic, Cerner, and others, utilizing industry standards like SMART on FHIR. This allows for direct data exchange to support automated prior authorization workflows without disrupting your current clinical systems.
What types of oncology treatments does Klivira cover regarding ASCO Guidelines?
Klivira's platform is designed to support prior authorization for a broad spectrum of oncology treatments, including chemotherapy, immunotherapy, radiation therapy, and supportive care, by applying relevant ASCO Guidelines. The specific coverage depends on the integrated payer policies and the ASCO criteria available in our knowledge base.
How does Klivira help reduce prior authorization denials related to ASCO Guidelines?
By automating the verification of ASCO Guidelines prior authorization criteria against patient data, Klivira ensures that all submitted requests are clinically complete and accurate. This proactive validation minimizes common reasons for denials, such as insufficient documentation or non-adherence to medical necessity standards, leading to higher first-pass approval rates.
Is Klivira compliant with healthcare data security standards for handling oncology patient information?
Absolutely. Klivira is built with robust security measures and operates in full compliance with HIPAA regulations and other applicable data privacy standards. We ensure the secure handling, transmission, and storage of all protected health information (PHI) involved in the prior authorization process.
Related coverage
Ready to operationalize these criteria in your PA workflow?
See how Klivira automates prior authorizations for your team.
Request a demo